Literature DB >> 16844732

Effectiveness of cervical cancer screening over cervical cancer mortality among Japanese women.

Khandoker Aklimunnessa1, Mitsuru Mori, M M H Khan, Fumio Sakauchi, Tatsuhiko Kubo, Yoshihisa Fujino, Sadao Suzuki, Shinkan Tokudome, Akiko Tamakoshi, Yutaka Motohashi, Ichiro Tsuji, Yosikazu Nakamura, Hiroyasu Iso, Haruo Mikami, Yutaka Inaba, Yoshiharu Hoshiyama, Hiroshi Suzuki, Hiroyuki Shimizu, Hideaki Toyoshima, Kenji Wakai, Yoshinori Ito, Shuji Hashimoto, Shogo Kikuchi, Akio Koizumi, Takashi Kawamura, Yoshiyuki Watanabe, Tsuneharu Miki, Chigusa Date, Kiyomi Sakata, Takayuki Nose, Norihiko Hayakawa, Takesumi Yoshimura, Akira Shibata, Naoyuki Okamoto, Hideo Shino, Yoshiyuki Ohno, Tomoyuki Kitagawa, Toshio Kuroki, Kazuo Tajima.   

Abstract

BACKGROUND: Various studies have revealed that cervical cancer (CC) screening significantly reduces both CC incidence and mortality in developed countries. Although Japan introduced a nationwide government funded annual CC screening for the women aged 30+ in 1982, the effectiveness of CC screening on CC mortality has not yet been evaluated by any prospective cohort study. Therefore, the present study evaluated the association of CC mortality with self-reported CC screening and some other factors by a nationwide cohort study.
METHODS: Baseline survey of the Japan Collaborative Cohort Study for the enrollment of subjects was completed during 1988-90 and followed until 2003. This study only analyzed 63,541 women, aged 30-79 years, who were free from any cancer history at enrollment.
RESULTS: During the follow-up period, 38 CC deaths were identified. The mean age at mortality was 67.0 years, with a mortality rate of 4.2 per 100,000 person-years. Participation rate in CC screening was 46.9%. Age-adjusted Cox model indicated significantly lower CC mortality [hazard ratio (HR) = 0.30, 95% confidence interval (CI) = 0.12-0.74] due to CC screening. Protectiveness remained almost the same (HR = 0.30, 95% CI = 0.12-0.76) when adjusted for age, body mass index and number of deliveries. The results also revealed that CC screening could reduce at least 50% of CC deaths even after excluding the effect of possible self-selection bias.
CONCLUSIONS: CC screening in Japan may reduce CC mortality significantly for women aged 30-79 years. However, further studies with more CC deaths and increased statistical power are needed to validate the findings.

Entities:  

Mesh:

Year:  2006        PMID: 16844732     DOI: 10.1093/jjco/hyl060

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  8 in total

1.  Psychological impact of positive cervical cancer screening results among Japanese women.

Authors:  Yukari Isaka; Haruhiko Inada; Yuri Hiranuma; Masao Ichikawa
Journal:  Int J Clin Oncol       Date:  2016-07-27       Impact factor: 3.402

2.  Current status of the National Cancer Screening Program for cervical cancer in Korea, 2009.

Authors:  Young Hwa Lee; Kui Son Choi; Hoo-Yeon Lee; Jae Kwan Jun
Journal:  J Gynecol Oncol       Date:  2012-01-09       Impact factor: 4.401

3.  Performance of papanicolaou testing and detection of cervical carcinoma in situ in participants of organized cervical cancer screening in South Korea.

Authors:  Mi Ah Han; Kui Son Choi; Hoo-Yeon Lee; Jae Kwan Jun; Kyu Won Jung; Sokbom Kang; Eun-Cheol Park
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

4.  Effectiveness of Visual Inspection with Acetic Acid (VIA) Screening on Cervical Cancer Mortality and Incidence - A Systematic Review and Meta-Analysis.

Authors:  Ayush Lohiya; Roy Arokiam Daniel; Durgesh Kumar; Cherian Varghese; Rama Shankar Rath; Rizwan S A; Baridalyne Nongkynrih
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

5.  Trends and Age-Period-Cohort Effects on the Incidence and Mortality Rate of Cervical Cancer in Korea.

Authors:  Eun-Kyeong Moon; Chang-Mo Oh; Young-Joo Won; Jong-Keun Lee; Kyu-Won Jung; Hyunsoon Cho; Jae Kwan Jun; Myong Cheol Lim; Moran Ki
Journal:  Cancer Res Treat       Date:  2016-09-01       Impact factor: 4.679

Review 6.  Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis.

Authors:  Cheng-Chieh Chen; Lee-Wen Huang; Chyi-Huey Bai; Chin-Cheng Lee
Journal:  Ann Saudi Med       Date:  2016 Jul-Aug       Impact factor: 1.526

Review 7.  Novel Antigenic Targets of HPV Therapeutic Vaccines.

Authors:  Ditte Rahbæk Boilesen; Karen Nørgaard Nielsen; Peter Johannes Holst
Journal:  Vaccines (Basel)       Date:  2021-11-01

8.  The association between cervical cancer screening participation and the deprivation index of the location of the family doctor's office.

Authors:  Fanny Serman; Jonathan Favre; Valérie Deken; Lydia Guittet; Claire Collins; Michaël Rochoy; Nassir Messaadi; Alain Duhamel; Ludivine Launay; Christophe Berkhout; Thibaut Raginel
Journal:  PLoS One       Date:  2020-05-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.